What is the most recent earnings date for BIO stock?
BIOTEST AG (BIO.DE) last reported earnings on 5/12/2025.
FRA:BIO • DE0005227201
Past quarterly earnings results for BIOTEST AG (BIO.DE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in EUR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2025 | - | - | 124.2M | - | -42.29% | |||
| Q4 2024 | - | - | 203.5M | - | 10.42% | |||
| Q3 2024 | - | - | 150.7M | - | -33.02% | |||
| Q2 2024 | - | - | 156.8M | - | 20.34% | |||
| Q1 2024 | - | - | 215.2M | - | 83.62% | |||
| Q4 2023 | - | - | 184.3M | - | 18.67% | |||
| Q3 2023 | - | - | 225M | - | 108.91% | |||
| Q2 2023 | - | - | 130.3M | - | -5.03% | |||
| Q1 2023 | - | - | 117.2M | - | 1.12% | |||
| Q4 2022 | 0.29 | - | 341.67% | 155.3M | 639.45M | -75.71% | 7.70% | |
| Q3 2022 | - | - | 107.7M | - | -5.19% | |||
| Q2 2022 | - | - | 137.2M | - | -0.44% | |||
| Q1 2022 | - | - | 115.9M | - | -3.42% | |||
| Q4 2021 | -0.12 | - | -1,112.00% | 144.2M | 532.875M | -72.94% | 1.12% | |
| Q3 2021 | - | - | 113.6M | - | 6.37% | |||
| Q2 2021 | - | - | 137.8M | - | 0.51% | |||
| Q1 2021 | - | - | 120M | - | 22.82% | |||
| Q4 2020 | -0.01 | -0.65 | 98.45% | - | 142.6M | 463.855M | -69.26% | - |
| Q3 2020 | -0.39 | - | - | 106.8M | - | - | ||
| Q2 2020 | -0.16 | - | - | 137.1M | - | - | ||
| Q1 2020 | -0.28 | - | - | 97.7M | - | - |
Notes
BIOTEST AG (BIO.DE) last reported earnings on 5/12/2025.
BIOTEST AG (BIO.DE) missed EPS estimates and missed revenue estimates in the most recent quarter.